ENDRA Life Sciences(NDRA) - 2025 Q4 - Annual Results

Exhibit 99.1 ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update ANN ARBOR, Mich. (March 31, 2026) – ENDRA Life Sciences Inc. (NASDAQ: NDRA) ("ENDRA" or the "Company"), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today reported financial results for the quarter and year ended December 31, 2025, and provided a business update. Business Update ● Initiated Evaluation of Strategic Alte ...